Molnupiravir
Specifications
2492423-29-5CAS Number
859-180-1EC Number
[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoateIUPAC Name
C13H19N3O7Chemical Formula
329.31 g/molMolecular Weight
molnupiravir; EIDD-2801; 2492423-29-5; Lagevrio; MK-4482; EIDD 2801; Uridine, 4-oxime, 5'-(2-methylpropanoate); YA84KI1VEW; Eidd 1931-isopropyl ester; EIDD-1931 ISOPROPYL ESTER; N4-Hydroxycytidine, 5'-isopropyl ester; EIDD2801; beta-D-N4 Hydroxycytidine-5'-isopropyl ester; CHEBI:180653; DTXSID501028058; MK4482; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate; ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4- dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate; Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-; RefChem:53379; CHEMBL4650320; MK 4482; SARS-CoV-2 antiviral agents: molnupiravir; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl)methyl 2-methylpropanoate; 859-180-1; 2349386-89-4; 2635324-86-4; ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate; [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate; Molnupiravir [INN]; Molnupiravir [USAN]; Molnupiravir [WHO-DD]; MFCD32663515; ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate; 2492423-30-8; ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate; [(2R,3S,4R,5R)-3,4-dihydroxy-5-[(4Z)-4-hydroxyimino-2-oxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methyl 2-methylpropanoate; [(2R,3S,4R,5R)-3,4-dihydroxy-5-[(4E)-4-(hydroxyimino)-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate; N-hydroxy-5'-O-(2-methylpropanoyl)cytidine; Molnupiravir Impurity 7; Molnupiravir (EIDD-2801); molnupiravirum; Lagevrio (TN); XMO; UNII-YA84KI1VEW; pro-EIDD-1931; Molnupiravir (JAN/USAN); MOLNUPIRAVIR [JAN]; EIDD-2801(Molnupiravir); EIDD-2801(Molnupiravir)?; orb1299050; orb1689082; SCHEMBL21345150; SCHEMBL23762545; SCHEMBL26089644; SCHEMBL29349707; EIDD 1931 5'-isopropylester; GTPL10737; med.21724, Compound 182; BDBM429508; DTXCID401767659; GLXC-22342; N4-hydroxycytidine isopropyl ester; Molnupiravir [USAN:INN:WHO-DD]; EX-A3432; MSK178990; WHO 11853; AKOS040758956; AT13078; N(4)-hydroxycytidine 5'-isopropylester; AC-35171; AE176721; AS-84465; IM181800; TS-09789; D11943; G70664; beta-D-N(4)-hydroxycytidine-5'-isopropyl ester; Uridine, 4-?oxime, 5'-?(2-?methylpropanoate); E325125; F987085; .BETA.-D-N4 HYDROXYCYTIDINE-5'-ISOPROPYL ESTER; N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine; |A-D-N4 hydroxycytidine-5 inverted exclamation marka-isopropyl ester; EIDD 2801, Uridine-5'-methylpropanoate-4-oxime, Lagevrio, MK-4482, prodrug-EIDD-1931; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate; ((2r,3s,4r,5r)-3,4-dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidine-1(2h)-yl)tetrahydrofuran-2-yl)methyl isobutyrate; ((2R3S4R5R)-34-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-34-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Isobutyrate; [(2R,3S,4R,5R)-3,4-bis(oxidanyl)-5-[4-(oxidanylamino)-2-oxidanylidene-pyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate; {(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoateSynonyms
No companies, products, or articles found for this substance yet.